Reduces peritumoral inflammation and cerebral edema DEX ameliorated cerebral edema by reducing the permeability of blood‐brain barrier, through regulating the expression level of occludin, claudin, and vascular endothelial (VE)‐cadherin thereby improving symptoms. The gene discussed is CDH17; the disease is edema.